[
  {
    "ts": "2025-09-11T15:32:00+00:00",
    "headline": "Encephalopathy Market Worth $209 Million in 2025 Led by Salix Pharma, Abbott Labs, and Fresenius Kabi: Analysis of Key Trends & Strategies",
    "summary": "The encephalopathy market offers opportunities in early intervention, advanced diagnostics, and multidisciplinary care. Growth is driven by digital therapeutics, patient-centric models, telemedicine, and regional adaptation. Strategic partnerships, personalized care, and supply chain resilience are critical for success. Encephalopathy Market Encephalopathy Market Dublin, Sept. 11, 2025 (GLOBE NEWSWIRE) -- The \"Encephalopathy Market - Global Forecast 2025-2030\" report has been added to ResearchAn",
    "url": "https://finance.yahoo.com/news/encephalopathy-market-worth-209-million-153200445.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "078f0865-98f7-3d04-a42a-de986c35e343",
      "content": {
        "id": "078f0865-98f7-3d04-a42a-de986c35e343",
        "contentType": "STORY",
        "title": "Encephalopathy Market Worth $209 Million in 2025 Led by Salix Pharma, Abbott Labs, and Fresenius Kabi: Analysis of Key Trends & Strategies",
        "description": "",
        "summary": "The encephalopathy market offers opportunities in early intervention, advanced diagnostics, and multidisciplinary care. Growth is driven by digital therapeutics, patient-centric models, telemedicine, and regional adaptation. Strategic partnerships, personalized care, and supply chain resilience are critical for success. Encephalopathy Market Encephalopathy Market Dublin, Sept. 11, 2025 (GLOBE NEWSWIRE) -- The \"Encephalopathy Market - Global Forecast 2025-2030\" report has been added to ResearchAn",
        "pubDate": "2025-09-11T15:32:00Z",
        "displayTime": "2025-09-11T15:32:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/6f1811fef52ee4e2857070fb5b829243",
          "originalWidth": 600,
          "originalHeight": 400,
          "caption": "Encephalopathy Market",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/bD4kpUGZ1GHY9i1jDyoLjg--~B/aD00MDA7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/6f1811fef52ee4e2857070fb5b829243.cf.webp",
              "width": 600,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/cEh6GSOd3xEf8tlUij3JhA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/6f1811fef52ee4e2857070fb5b829243.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/encephalopathy-market-worth-209-million-153200445.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/encephalopathy-market-worth-209-million-153200445.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]